image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 31.43
-1.47 %
$ 1.08 B
Market Cap
47.62
P/E
1. INTRINSIC VALUE

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support.[ Read More ]

The intrinsic value of one PNTG stock under the base case scenario is HIDDEN Compared to the current market price of 31.4 USD, The Pennant Group, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart PNTG

image
FINANCIALS
545 M REVENUE
15.14%
25.2 M OPERATING INCOME
27.94%
13.9 M NET INCOME
92.05%
33.1 M OPERATING CASH FLOW
265.88%
-30.2 M INVESTING CASH FLOW
-24.68%
1.11 M FINANCING CASH FLOW
-90.80%
181 M REVENUE
7.08%
10.8 M OPERATING INCOME
8.37%
7.21 M NET INCOME
26.77%
7.69 M OPERATING CASH FLOW
-26.67%
-33 M INVESTING CASH FLOW
-242.25%
26.7 M FINANCING CASH FLOW
5182.70%
Balance Sheet Decomposition The Pennant Group, Inc.
image
Current Assets 80.1 M
Cash & Short-Term Investments 6.06 M
Receivables 61.1 M
Other Current Assets 12.9 M
Non-Current Assets 460 M
Long-Term Investments 0
PP&E 292 M
Other Non-Current Assets 168 M
Current Liabilities 71.5 M
Accounts Payable 10.8 M
Short-Term Debt 34.2 M
Other Current Liabilities 26.5 M
Non-Current Liabilities 323 M
Long-Term Debt 313 M
Other Non-Current Liabilities 10.1 M
EFFICIENCY
Earnings Waterfall The Pennant Group, Inc.
image
Revenue 545 M
Cost Of Revenue 483 M
Gross Profit 61.9 M
Operating Expenses 89 M
Operating Income 25.2 M
Other Expenses 11.3 M
Net Income 13.9 M
RATIOS
11.36% GROSS MARGIN
11.36%
4.62% OPERATING MARGIN
4.62%
2.46% NET MARGIN
2.46%
9.53% ROE
9.53%
2.48% ROA
2.48%
8.08% ROIC
8.08%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis The Pennant Group, Inc.
image
Net Income 13.9 M
Depreciation & Amortization 5.13 M
Capital Expenditures -8.1 M
Stock-Based Compensation 5.37 M
Change in Working Capital 3.44 M
Others 13.9 M
Free Cash Flow 25 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets The Pennant Group, Inc.
image
Wall Street analysts predict an average 1-year price target for PNTG of $28.8 , with forecasts ranging from a low of $18 to a high of $38 .
PNTG Lowest Price Target Wall Street Target
18 USD -42.73%
PNTG Average Price Target Wall Street Target
28.8 USD -8.26%
PNTG Highest Price Target Wall Street Target
38 USD 20.90%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership The Pennant Group, Inc.
image
Sold
0-3 MONTHS
62 K USD 2
3-6 MONTHS
10.6 K USD 1
6-9 MONTHS
31.2 K USD 2
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
3 weeks ago
Oct 23, 2024
Sell 12.8 K USD
Stringfield JoAnne
Director
- 380
33.56 USD
2 months ago
Aug 27, 2024
Sell 48.9 K USD
Guerisoli Brent
President
- 1407
34.741 USD
2 months ago
Aug 27, 2024
Sell 382 USD
Guerisoli Brent
President
- 11
34.741 USD
3 months ago
Jul 23, 2024
Sell 3.19 K USD
Stringfield JoAnne
Director
- 114
28 USD
3 months ago
Jul 23, 2024
Sell 7.45 K USD
Stringfield JoAnne
Director
- 266
28 USD
6 months ago
Apr 19, 2024
Sell 2.77 K USD
Stringfield JoAnne
Director
- 140
19.78 USD
6 months ago
Apr 19, 2024
Sell 4.75 K USD
Stringfield JoAnne
Director
- 240
19.78 USD
8 months ago
Feb 23, 2024
Sell 23.7 K USD
Guerisoli Brent
President
- 1385
17.11 USD
1 year ago
May 30, 2023
Sell 7.12 K USD
Freeman Jennifer
- 611
11.65 USD
1 year ago
May 11, 2023
Bought 13.6 K USD
Gochnour John J
Chief Operating Officer
+ 1232
11.04 USD
1 year ago
Apr 18, 2023
Sell 2.53 K USD
Stringfield JoAnne
Director
- 190
13.31 USD
1 year ago
Apr 19, 2023
Sell 1.18 K USD
Stringfield JoAnne
Director
- 95
12.45 USD
1 year ago
Mar 06, 2023
Bought 383 K USD
SMITH BARRY M
Director
+ 25536
14.998 USD
1 year ago
Mar 03, 2023
Bought 66.7 K USD
SMITH BARRY M
Director
+ 4464
14.947 USD
1 year ago
Jan 18, 2023
Sell 1.04 K USD
Stringfield JoAnne
Director
- 95
10.96 USD
1 year ago
Jan 19, 2023
Sell 1.08 K USD
Stringfield JoAnne
Director
- 95
11.37 USD
1 year ago
Nov 30, 2022
Bought 203 K USD
Nackel John G.
Director
+ 20000
10.13 USD
2 years ago
Oct 24, 2022
Sell 3.1 K USD
Stringfield JoAnne
Director
- 285
10.89 USD
2 years ago
Oct 25, 2022
Sell 2.05 K USD
Stringfield JoAnne
Director
- 190
10.81 USD
2 years ago
Jul 14, 2022
Sell 11.8 K USD
Freeman Jennifer
Chief Financial Officer
- 1102
10.75 USD
2 years ago
Jun 10, 2022
Sell 45.7 K USD
Christensen Christopher R.
director:
- 2818
16.2 USD
2 years ago
Apr 18, 2022
Bought 44 K USD
Christensen Christopher R.
director:
+ 2668
16.5 USD
2 years ago
Apr 18, 2022
Sell 3.14 K USD
Stringfield JoAnne
director:
- 190
16.5 USD
2 years ago
Apr 14, 2022
Bought 94.5 K USD
Christensen Christopher R.
Director
+ 5729
16.4992 USD
2 years ago
Apr 13, 2022
Bought 356 K USD
Christensen Christopher R.
director:
+ 21603
16.4993 USD
2 years ago
Jan 18, 2022
Sell 3.31 K USD
Stringfield JoAnne
Director
- 190
17.4 USD
3 years ago
Oct 18, 2021
Sell 4.86 K USD
Stringfield JoAnne
Director
- 190
25.57 USD
3 years ago
Jun 21, 2021
Sell 225 K USD
Walker Daniel H
Chief Executive Officer
- 5100
44.026 USD
3 years ago
Jun 15, 2021
Sell 2 M USD
Walker Daniel H
Chief Executive Officer
- 50000
40.078 USD
3 years ago
Jun 17, 2021
Sell 841 K USD
Walker Daniel H
Chief Executive Officer
- 20000
42.032 USD
3 years ago
May 28, 2021
Sell 20.6 K USD
Freeman Jennifer
Chief Financial Officer
- 621
33.24 USD
3 years ago
Apr 15, 2021
Sell 4.1 K USD
Stringfield JoAnne
Director
- 95
43.14 USD
3 years ago
Feb 02, 2021
Sell 1.16 M USD
Walker Daniel H
Chief Executive Officer
- 21401
54.23 USD
3 years ago
Feb 02, 2021
Sell 41.7 K USD
Walker Daniel H
Chief Executive Officer
- 752
55.46 USD
3 years ago
Feb 02, 2021
Sell 11.2 K USD
Walker Daniel H
Chief Executive Officer
- 200
56.2 USD
3 years ago
Feb 03, 2021
Sell 175 K USD
Walker Daniel H
Chief Executive Officer
- 3200
54.68 USD
3 years ago
Feb 03, 2021
Sell 246 K USD
Walker Daniel H
Chief Executive Officer
- 4447
55.3 USD
3 years ago
Jan 19, 2021
Sell 5.55 K USD
Stringfield JoAnne
Director
- 95
58.37 USD
3 years ago
Jan 15, 2021
Sell 122 K USD
Walker Daniel H
Chief Executive Officer
- 2128
57.11 USD
3 years ago
Jan 15, 2021
Sell 454 K USD
Walker Daniel H
Chief Executive Officer
- 7835
57.98 USD
3 years ago
Jan 15, 2021
Sell 1.06 M USD
Walker Daniel H
Chief Executive Officer
- 17948
59.04 USD
3 years ago
Jan 15, 2021
Sell 605 K USD
Walker Daniel H
Chief Executive Officer
- 10089
59.92 USD
3 years ago
Jan 15, 2021
Sell 73.1 K USD
Walker Daniel H
Chief Executive Officer
- 1200
60.95 USD
3 years ago
Jan 15, 2021
Sell 49.9 K USD
Walker Daniel H
Chief Executive Officer
- 800
62.33 USD
3 years ago
Dec 24, 2020
Sell 20.2 K USD
Christensen Christopher R.
Director
- 341
59.31 USD
3 years ago
Dec 24, 2020
Sell 46.5 K USD
Christensen Christopher R.
Director
- 774
60.02 USD
3 years ago
Dec 21, 2020
Sell 41.1 K USD
Christensen Christopher R.
Director
- 700
58.66 USD
3 years ago
Dec 21, 2020
Sell 767 K USD
Christensen Christopher R.
Director
- 12854
59.7 USD
3 years ago
Dec 21, 2020
Sell 182 K USD
Christensen Christopher R.
Director
- 3018
60.22 USD
3 years ago
Dec 21, 2020
Sell 12.3 K USD
Christensen Christopher R.
Director
- 200
61.65 USD
3 years ago
Dec 22, 2020
Sell 201 K USD
Christensen Christopher R.
Director
- 3399
59.03 USD
3 years ago
Dec 22, 2020
Sell 202 K USD
Christensen Christopher R.
Director
- 3383
59.73 USD
3 years ago
Dec 22, 2020
Sell 344 K USD
Christensen Christopher R.
Director
- 5648
60.99 USD
3 years ago
Dec 23, 2020
Sell 948 K USD
Christensen Christopher R.
Director
- 15815
59.94 USD
3 years ago
Dec 23, 2020
Sell 233 K USD
Christensen Christopher R.
Director
- 3868
60.32 USD
4 years ago
Oct 22, 2020
Sell 1.82 M USD
Walker Daniel H
Chief Executive Officer
- 45447
40.054 USD
4 years ago
Oct 23, 2020
Sell 17 K USD
Walker Daniel H
Chief Executive Officer
- 418
40.7 USD
4 years ago
Oct 23, 2020
Sell 23.8 K USD
Walker Daniel H
Chief Executive Officer
- 573
41.53 USD
4 years ago
Oct 23, 2020
Sell 9.14 K USD
Walker Daniel H
Chief Executive Officer
- 215
42.49 USD
4 years ago
Oct 16, 2020
Sell 90.1 K USD
Walker Daniel H
Chief Executive Officer
- 2247
40.1 USD
4 years ago
Oct 16, 2020
Sell 90.1 K USD
Walker Daniel H
Chief Executive Officer
- 2247
40.1 USD
4 years ago
Oct 16, 2020
Sell 3.71 K USD
Stringfield JoAnne
Director
- 95
39.08 USD
4 years ago
Oct 12, 2020
Sell 12 K USD
Walker Daniel H
Chief Executive Officer
- 300
40.01 USD
4 years ago
Oct 12, 2020
Sell 328 K USD
Walker Daniel H
Chief Executive Officer
- 7800
42.03 USD
4 years ago
Oct 12, 2020
Sell 94.9 K USD
Walker Daniel H
Chief Executive Officer
- 2200
43.15 USD
4 years ago
Oct 12, 2020
Sell 30.9 K USD
Walker Daniel H
Chief Executive Officer
- 700
44.14 USD
4 years ago
Oct 12, 2020
Sell 4.55 K USD
Walker Daniel H
Chief Executive Officer
- 100
45.47 USD
4 years ago
Oct 12, 2020
Sell 12 K USD
Walker Daniel H
Chief Executive Officer
- 300
40.01 USD
4 years ago
Oct 12, 2020
Sell 94.9 K USD
Walker Daniel H
Chief Executive Officer
- 2200
43.15 USD
4 years ago
Oct 12, 2020
Sell 30.9 K USD
Walker Daniel H
Chief Executive Officer
- 700
44.14 USD
4 years ago
Oct 12, 2020
Sell 4.55 K USD
Walker Daniel H
Chief Executive Officer
- 100
45.47 USD
4 years ago
Oct 12, 2020
Sell 328 K USD
Walker Daniel H
Chief Executive Officer
- 7800
42.03 USD
4 years ago
May 27, 2020
Sell 1.13 K USD
Bunker Derek J
Chief Investment Officer
- 43
26.21 USD
4 years ago
May 27, 2020
Sell 1.13 K USD
Bunker Derek J
Chief Investment Officer
- 43
26.21 USD
4 years ago
Mar 13, 2020
Bought 98.4 K USD
Lamb Scott E
Director
+ 6300
15.62 USD
4 years ago
Feb 07, 2020
Sell 1.87 K USD
Bunker Derek J
Chief Investment Officer
- 69
27.03 USD
5 years ago
Nov 18, 2019
Bought 103 K USD
Lamb Scott E
Director
+ 5085
20.2023 USD
7. News
Pennant Group to Participate in the 2024 Stephens Annual Investment Conference EAGLE, Idaho, Nov. 11, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2024 Stephens Annual Investment Conference on November 19-20, 2024. Brent Guerisoli, Chief Executive Officer, Lynette Walbom, Chief Financial Officer, and John Gochnour, President and Chief Operating Officer, will participate in a fireside chat on November 19, 2024 at 10:00 a.m. globenewswire.com - 5 days ago
DGX vs. PNTG: Which Stock Is the Better Value Option? Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Quest Diagnostics (DGX) and The Pennant Group, Inc. (PNTG). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 5 days ago
The Pennant Group Inc (PNTG) Q3 2024 Earnings Call Transcript The Pennant Group Inc (NASDAQ:PNTG ) Q3 2024 Earnings Call Transcript November 7, 2024 12:00 PM ET Company Participants Kirk Cheney - General Counsel & Corporate Secretary Brent Guerisoli - Chief Executive Officer & Director John Gochnour - President & Chief Operating Officer Lynette Walbom - Chief Financial Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Scott Fidel - Stephens Operator Good day, and thank you for standing by. Welcome to The Pennant Group's Third Quarter 2024 Earnings Conference Call. seekingalpha.com - 6 days ago
The Pennant Group (PNTG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for The Pennant Group (PNTG) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com - 1 week ago
The Pennant Group, Inc. (PNTG) Q3 Earnings and Revenues Beat Estimates The Pennant Group, Inc. (PNTG) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.20 per share a year ago. zacks.com - 1 week ago
Pennant Reports Third Quarter 2024 Results Conference Call and Webcast scheduled for tomorrow, November 7, 2024 at 10:00 am MT Conference Call and Webcast scheduled for tomorrow, November 7, 2024 at 10:00 am MT globenewswire.com - 1 week ago
Pennant Acquires Senior Living Communities in Wisconsin EAGLE, Idaho, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it has acquired the operations of the following premier senior living facilities in Green Bay and Appleton, Wisconsin. The acquisition is effective today, November 1, 2024, and will be subject to a long-term, triple net lease: globenewswire.com - 2 weeks ago
DGX or PNTG: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Quest Diagnostics (DGX) or The Pennant Group, Inc. (PNTG). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 3 weeks ago
Pennant Announces Third Quarter 2024 Earnings Release and Call EAGLE, Idaho, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its third quarter 2024 financial results on Wednesday, November 6, 2024. globenewswire.com - 3 weeks ago
The Pennant Group Announces Pricing of Public Offering of Common Stock EAGLE, Idaho, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG) (the “Company”) today announced the pricing of an underwritten public offering of 3,500,000 shares of its common stock at a public offering price of $31.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $108.5 million. globenewswire.com - 1 month ago
Here is Why Growth Investors Should Buy The Pennant Group (PNTG) Now The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market. zacks.com - 1 month ago
The Pennant Group Announces Public Offering of Common Stock EAGLE, Idaho, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG) (the “Company”) today announced that it has commenced an underwritten public offering of 3,500,000 shares of common stock of the Company. globenewswire.com - 1 month ago
8. Profile Summary

The Pennant Group, Inc. PNTG

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 1.08 B
Dividend Yield 0.00%
Description The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Contact 1675 East Riverside Drive, Eagle, ID, 83616 https://www.pennantgroup.com
IPO Date Oct. 1, 2019
Employees 5791
Officers Ms. Lynette B. Walbom CPA Chief Financial Officer Mr. John J. Gochnour President & Chief Operating Officer Mr. Kirk S. Cheney General Counsel & Corporate Secretary Mr. Brian W. Wayment President of Cornerstone Healthcare Mr. Jason P. Steik Chief Clinical Officer Mr. Brent J. Guerisoli Chief Executive Officer & Director